Actovegin 40mg 2ml N25 ampoule (Takeda)

Actovegin 40mg 2ml N25 ampoule (Takeda)

Composition and directions for use

Actovegin injection solution contains a deproteinized calf blood extract as the active ingredient. Each 2 ml ampoule contains 40 mg of the active substance. The product is manufactured by Takeda and meets high quality standards.

The medicine is administered intravenously, intramuscularly, or intra-arterially. The dosage is determined by the doctor depending on the patient’s condition and severity. Typically, the initial dose is 10–15 ml per day.

Injections should be given slowly and under sterile conditions. The course of treatment usually lasts 10–20 days. The effect of the drug begins on the 2nd–3rd day of treatment and gradually strengthens.

Key features and contraindications

Actovegin improves tissue metabolism by increasing the uptake of oxygen and glucose at the cellular level. The drug is effective in disorders of cerebral blood circulation, wound healing, and diabetic neuropathy. The product is also used as an adjunct in the treatment of cardiovascular diseases. Actovegin increases cells’ resistance to oxygen deficiency and accelerates reparative processes.

The main contraindications include individual hypersensitivity to the components, severe heart failure, and hypernatremia. During pregnancy and breastfeeding, it should be used only under medical supervision. Rarely, allergic reactions, headache, and local irritation may occur. Since Actovegin may interact with other medicines, it is important to inform the doctor before starting treatment.